JP2023512196A5 - - Google Patents
Info
- Publication number
- JP2023512196A5 JP2023512196A5 JP2022545429A JP2022545429A JP2023512196A5 JP 2023512196 A5 JP2023512196 A5 JP 2023512196A5 JP 2022545429 A JP2022545429 A JP 2022545429A JP 2022545429 A JP2022545429 A JP 2022545429A JP 2023512196 A5 JP2023512196 A5 JP 2023512196A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- taa
- antibody molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025193397A JP2026041756A (ja) | 2020-01-29 | 2025-11-13 | 抗ｍｄｒ１抗体およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062967470P | 2020-01-29 | 2020-01-29 | |
| US62/967,470 | 2020-01-29 | ||
| US202063085818P | 2020-09-30 | 2020-09-30 | |
| US63/085,818 | 2020-09-30 | ||
| PCT/US2021/015534 WO2021155028A1 (en) | 2020-01-29 | 2021-01-28 | Anti-mdr1 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025193397A Division JP2026041756A (ja) | 2020-01-29 | 2025-11-13 | 抗ｍｄｒ１抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512196A JP2023512196A (ja) | 2023-03-24 |
| JP2023512196A5 true JP2023512196A5 (enExample) | 2024-02-02 |
| JP7815595B2 JP7815595B2 (ja) | 2026-02-18 |
Family
ID=74673398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545429A Active JP7815595B2 (ja) | 2020-01-29 | 2021-01-28 | 抗ｍｄｒ１抗体およびその使用 |
| JP2025193397A Pending JP2026041756A (ja) | 2020-01-29 | 2025-11-13 | 抗ｍｄｒ１抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025193397A Pending JP2026041756A (ja) | 2020-01-29 | 2025-11-13 | 抗ｍｄｒ１抗体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230203156A1 (enExample) |
| EP (1) | EP4097134A1 (enExample) |
| JP (2) | JP7815595B2 (enExample) |
| KR (1) | KR20220133884A (enExample) |
| CN (1) | CN115023443A (enExample) |
| AU (1) | AU2021214370A1 (enExample) |
| BR (1) | BR112022013870A2 (enExample) |
| CA (1) | CA3164608A1 (enExample) |
| MX (1) | MX2022009355A (enExample) |
| WO (1) | WO2021155028A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41463A (fr) * | 2015-02-03 | 2017-12-12 | Anaptysbio Inc | Anticorps dirigés contre le gène d'activation 3 des lymphocytes (lag-3) |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| US20250051471A1 (en) * | 2021-12-13 | 2025-02-13 | William Robert Arathoon Living Trust Dated August 29, 2016 | Anti-Abcb1 Antibodies |
| WO2023159220A1 (en) | 2022-02-18 | 2023-08-24 | Kenjockety Biotechnology, Inc. | Anti-cd47 antibodies |
| CN120957755A (zh) * | 2023-05-12 | 2025-11-14 | 四川科伦博泰生物医药股份有限公司 | 多环类药物偶联物及其制备方法和用途 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| WO2025232118A1 (zh) * | 2024-05-10 | 2025-11-13 | 四川科伦博泰生物医药股份有限公司 | 稠环类化合物及其制备方法和用途 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| TW197439B (enExample) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| JPH08500973A (ja) | 1992-05-21 | 1996-02-06 | ザ ペン ステイト リサーチ ファウンデーション | タキソール、関連タキサン及び他の新規な抗癌／抗ウイルス性化合物原料としてのイチイ培養組織 |
| US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
| US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
| FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
| FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| US5824701A (en) | 1993-10-20 | 1998-10-20 | Enzon, Inc. | Taxane-based prodrugs |
| US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| US5686578A (en) * | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| AU3740997A (en) | 1996-08-26 | 1998-03-19 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
| WO1998013059A1 (en) | 1996-09-27 | 1998-04-02 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| AU4966597A (en) | 1996-11-19 | 1998-06-10 | Daiichi Pharmaceutical Co., Ltd. | Taxol derivatives |
| US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
| JP2002505682A (ja) | 1997-06-20 | 2002-02-19 | ベーカー ノートン ファーマシューティカルズ インコーポレイテッド | パクリタクセルの可溶性プロドラッグ |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| JPH1192468A (ja) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | 新規なタキサン誘導体 |
| WO1999018113A1 (fr) | 1997-10-08 | 1999-04-15 | Bio Research Corporation Of Yokohama | Derives taxoides et leur procede de production |
| EP1865987A2 (en) * | 2005-04-06 | 2007-12-19 | Cedars-Sinai Medical Center | Inhibition of p-glycoprotein by treatment with a class of modulators and the uic2 monoclonal antibody |
| CN110655582B (zh) * | 2015-01-08 | 2022-12-16 | 江苏康宁杰瑞生物制药有限公司 | 具有共同轻链的双特异性抗体或抗体混合物 |
| BR112019010878A2 (pt) | 2016-11-29 | 2019-10-01 | Lindhofer Horst | combinação de anticorpos multifuncionais de redirecionamento de células t com moduladores de ponto de verificação imunológico e usos dos mesmos |
| WO2019080883A1 (en) | 2017-10-26 | 2019-05-02 | Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd. | NOVEL RECOMBINANT FUSION PROTEINS, PREPARATION THEREOF AND USE THEREOF |
| JP7716623B2 (ja) | 2019-04-02 | 2025-08-01 | ウィリアム ロバート アラスーン リビング トラスト デイテッド オーガスト 29, 2016 | 排出ポンプ－癌抗原マルチ特異性抗体ならびにそれに関する組成物、試薬、キットおよび方法 |
-
2021
- 2021-01-28 WO PCT/US2021/015534 patent/WO2021155028A1/en not_active Ceased
- 2021-01-28 US US17/793,804 patent/US20230203156A1/en active Pending
- 2021-01-28 AU AU2021214370A patent/AU2021214370A1/en active Pending
- 2021-01-28 CN CN202180011803.5A patent/CN115023443A/zh active Pending
- 2021-01-28 JP JP2022545429A patent/JP7815595B2/ja active Active
- 2021-01-28 EP EP21707532.4A patent/EP4097134A1/en active Pending
- 2021-01-28 CA CA3164608A patent/CA3164608A1/en active Pending
- 2021-01-28 MX MX2022009355A patent/MX2022009355A/es unknown
- 2021-01-28 BR BR112022013870A patent/BR112022013870A2/pt not_active Application Discontinuation
- 2021-01-28 KR KR1020227025808A patent/KR20220133884A/ko active Pending
-
2025
- 2025-11-13 JP JP2025193397A patent/JP2026041756A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512196A5 (enExample) | ||
| JP2020011980A5 (enExample) | ||
| JP2017048240A5 (enExample) | ||
| JP2021054859A5 (enExample) | ||
| JP2020512314A5 (enExample) | ||
| JP2022527860A5 (enExample) | ||
| JP2013510868A5 (enExample) | ||
| JP2021500926A5 (enExample) | ||
| JP2019532023A5 (enExample) | ||
| JP2018516911A5 (enExample) | ||
| JP2020502271A5 (enExample) | ||
| RU2019116661A (ru) | Антитела против pd-l1 и их варианты | |
| JP2016537383A5 (enExample) | ||
| JP2019524701A5 (enExample) | ||
| JP2011502517A5 (enExample) | ||
| RU2020102237A (ru) | Связывающие il-1-бета антитела для применения в лечении рака | |
| JP2008531576A5 (enExample) | ||
| RU2018124319A (ru) | Новые антитела к клаудину и способы их применения | |
| RU2011111746A (ru) | Композиции рекомбинантных антител против рецептора эпидермального фактора роста | |
| JP2020501598A5 (enExample) | ||
| JP2018536632A5 (ja) | Ｂ７‐ｈ３に特異的に結合する分子及びｐｄ‐１に特異的に結合する分子 | |
| JP2017521054A5 (enExample) | ||
| JP2013523843A5 (enExample) | ||
| JP2022512750A5 (enExample) | ||
| PE20231386A1 (es) | Anticuerpos biespecificos contra ceacam5 y cd47 |